4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-24-020108
CHAIRMAN & CEO sold 136,124 shares at an average $25.65 ($3,491,947)
- CHAIRMAN & CEO acquired 136,124 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Sanj K CHAIRMAN & CEO | 2024-07-23 | Option exercise 10b5-1 | +136,124 | $1.59 | $216,437 | 199,136 | D |
| Patel Sanj K CHAIRMAN & CEO | 2024-07-23 | Sale 10b5-1 | −23,075 | $23.25 | $536,494 | 176,061 | D |
| Patel Sanj K CHAIRMAN & CEO | 2024-07-23 | Sale 10b5-1 | −50,000 | $25.05 | $1,252,500 | 126,061 | D |
| Patel Sanj K CHAIRMAN & CEO | 2024-07-23 | Sale 10b5-1 | −63,049 | $27.01 | $1,702,953 | 63,012 | D |
| Derivatives | |||||||
| Patel Sanj K CHAIRMAN & CEO | 2024-07-23 | Option exercise · Share Option 10b5-1 | −136,124 | 189,147 | D | ||
| Open-market sales · 136,124 sh · avg $25.65 · $3,491,947 | |||||||
Loading xslF345X05/form4-07252024_080727.xml…